Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 4
Submit an article Journal homepage
2,054
Views
25
CrossRef citations to date
0
Altmetric
Letter to the Editor

A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genes

Hubert HacklBiocenter, Division of Bioinformatics, Innsbruck Medical University, Innsbruck, Austria
,
Katarina SteinleitnerDepartment of Medicine I, Medical University of Vienna, Vienna, Austria;Comprehensive Cancer Center of the Medical University of Vienna, Vienna, Austria
,
Karin LindDivision of Hematology, Medical University of Graz, Graz, Austria
,
Sybille HoferDivision of Hematology, Medical University of Graz, Graz, Austria
,
Natasa TosicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia
,
Sonja PavlovicInstitute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia
,
Nada SuvajdzicClinic of Hematology, Clinical Center of Serbia, University of Belgrade, Belgrade, Serbia
,
Heinz SillDivision of Hematology, Medical University of Graz, Graz, Austria
&
Rotraud WieserDepartment of Medicine I, Medical University of Vienna, Vienna, Austria;Comprehensive Cancer Center of the Medical University of Vienna, Vienna, AustriaCorrespondence[email protected]
 show all
Pages 1126-1128 | Received 24 Jan 2014, Accepted 06 Jul 2014, Published online: 18 Aug 2014

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sabrina Mariani, Silvia Maria Trisolini, Clara Minotti, Massimo Breccia, Claudio Cartoni, Maria Stefania De Propris, Giovanna Loglisci, Roberto Latagliata, Maria Zaira Limongi, Anna Maria Testi, Robin Foà & Saveria Capria. (2021) Very late acute myeloid leukemia relapse: clinical features, treatment and outcome. Leukemia & Lymphoma 62:4, pages 1022-1025.
Read now

Articles from other publishers (24)

Laia Cuesta-Casanovas, Jennifer Delgado-Martínez, Josep M. Cornet-Masana, José M. Carbó, Antònia Banús-Mulet, Francesca Guijarro, Jordi Esteve & Ruth M. Risueño. (2023) Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia. Cancer Cell International 23:1.
Crossref
Alban Canali, Inès Vergnolle, Sarah Bertoli, Laetitia Largeaud, Marie-Laure Nicolau, Jean-Baptiste Rieu, Suzanne Tavitian, Françoise Huguet, Muriel Picard, Pierre Bories, Jean Philippe Vial, Nicolas Lechevalier, Marie Christine Béné, Isabelle Luquet, Véronique Mansat-De Mas, Eric Delabesse, Christian Récher & François Vergez. (2023) Prognostic Impact of Unsupervised Early Assessment of Bulk and Leukemic Stem Cell Measurable Residual Disease in Acute Myeloid Leukemia. Clinical Cancer Research 29:1, pages 134-142.
Crossref
Jialan Niu, Danyue Peng & Lingbo Liu. (2022) Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells. Frontiers in Oncology 12.
Crossref
Haoyu Liu, Xu Zhang, Ziyan Zhao, Hongying Zhu, Danyang Li, Yang Yang, Wenbo Zhao, Fei Zhang, Yuefeng Wang, Lina Zhu, Zewen Ding & Xiangzhi Li. (2022) CNST is Characteristic of Leukemia Stem Cells and is Associated With Poor Prognosis in AML. Frontiers in Pharmacology 13.
Crossref
Svea Stratmann, Sara A. Yones, Mateusz Garbulowski, Jitong Sun, Aron SkaftasonMarkus MayrhoferNina Norgren, Morten Krogh Herlin, Christer Sundström, Anna Eriksson, Martin Höglund, Josefine PalleJonas AbrahamssonKirsi JahnukainenMonica Cheng Munthe-KaasBernward ZellerKatja Pokrovskaja TammLucia Cavelier, Jan Komorowski & Linda Holmfeldt. (2022) Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression. Blood Advances 6:1, pages 152-164.
Crossref
Zineng Huang, Huifang Zhang, Cheng Xing, Lei Zhang, Hongkai Zhu, Zeyu Deng, Le Yin, En Dong, Canfei Wang & Hongling Peng. (2022) Identification and validation of CALCRL-associated prognostic genes in acute myeloid leukemia. Gene 809, pages 146009.
Crossref
Eimear O'Reilly, Hojjat Alizadeh Zeinabad & Eva Szegezdi. (2021) Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities. Blood Reviews 50, pages 100850.
Crossref
Alexander Michael Grandits, Chi Huu Nguyen, Angela Schlerka, Hubert Hackl, Heinz Sill, Julia Etzler, Elizabeth Heyes, Dagmar Stoiber, Florian Grebien, Gerwin Heller & Rotraud Wieser. (2021) Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness. Leukemia 35:10, pages 2827-2839.
Crossref
Alexander M. Grandits & Rotraud Wieser. (2021) Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A. Experimental Hematology 99, pages 1-11.
Crossref
Qingsheng Huang, Jiayong Zhong, Huan Gao, Kuanrong Li & Huiying Liang. (2021) Subgrouping by gene expression profiles to improve relapse risk prediction in paediatric B‐precursor acute lymphoblastic leukaemia. Cancer Medicine 10:11, pages 3782-3793.
Crossref
Hassan Dakik, Maya El Dor, Joan Leclerc, Farah Kouzi, Ali Nehme, Margaux Deynoux, Christelle Debeissat, Georges Khamis, Elfi Ducrocq, Aida Ibrik, Marie-José Stasia, Houssam Raad, Hamid Reza Rezvani, Fabrice Gouilleux, Kazem Zibara, Olivier Herault & Frédéric Mazurier. (2021) Characterization of NADPH Oxidase Expression and Activity in Acute Myeloid Leukemia Cell Lines: A Correlation with the Differentiation Status. Antioxidants 10:3, pages 498.
Crossref
Christian Récher. (2021) Clinical Implications of Inflammation in Acute Myeloid Leukemia. Frontiers in Oncology 11.
Crossref
Maëlle Cartel, Pierre-Luc Mouchel, Mathilde Gotanègre, Laure David, Sarah Bertoli, Véronique Mansat-De Mas, Arnaud Besson, Jean-Emmanuel Sarry, Stéphane Manenti & Christine Didier. (2020) Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy. Leukemia 35:2, pages 417-432.
Crossref
Clément Larrue, Nathan Guiraud, Pierre-Luc Mouchel, Marine Dubois, Thomas Farge, Mathilde Gotanègre, Claudie Bosc, Estelle Saland, Marie-Laure Nicolau-Travers, Marie Sabatier, Nizar Serhan, Ambrine Sahal, Emeline Boet, Sarah Mouche, Quentin Heydt, Nesrine Aroua, Lucille Stuani, Tony Kaoma, Linus Angenendt, Jan-Henrik Mikesch, Christoph Schliemann, François Vergez, Jérôme Tamburini, Christian Récher & Jean-Emmanuel Sarry. (2021) Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells. Nature Communications 12:1.
Crossref
Toshihiko Oki, Francois Mercier, Hiroki Kato, Yookyung Jung, Thomas O. McDonald, Joel A. Spencer, Michael C. Mazzola, Nick van Gastel, Charles P. Lin, Franziska Michor, Toshio Kitamura & David T. Scadden. (2021) Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AML. Nature Communications 12:1.
Crossref
François Vergez, Marie-Laure Nicolau-Travers, Sarah Bertoli, Jean-Baptiste Rieu, Suzanne Tavitian, Pierre Bories, Isabelle Luquet, Véronique De Mas, Laetitia Largeaud, Audrey Sarry, Françoise Huguet, Eric Delabesse, Emilie Bérard & Christian Récher. (2020) CD34+CD38−CD123+ Leukemic Stem Cell Frequency Predicts Outcome in Older Acute Myeloid Leukemia Patients Treated by Intensive Chemotherapy but Not Hypomethylating Agents. Cancers 12:5, pages 1174.
Crossref
Tobias Gluexam, Alexander M. Grandits, Angela Schlerka, Chi Huu Nguyen, Julia Etzler, Thomas Finkes, Michael Fuchs, Christoph Scheid, Gerwin Heller, Hubert Hackl, Nathalie Harrer, Heinz Sill, Elisabeth Koller, Dagmar Stoiber, Wolfgang Sommergruber & Rotraud Wieser. (2019) CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia. International Journal of Molecular Sciences 20:23, pages 5826.
Crossref
Chi Huu Nguyen, Tobias Glüxam, Angela Schlerka, Katharina Bauer, Alexander M. Grandits, Hubert Hackl, Oliver Dovey, Sabine Zöchbauer-Müller, Jonathan L. Cooper, George S. Vassiliou, Dagmar Stoiber, Rotraud Wieser & Gerwin Heller. (2019) SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness. Scientific Reports 9:1.
Crossref
Nickolas Steinauer, Chun Guo, Chunfa Huang, Madeline Wong, Yifan Tu, Carl E. Freter & Jinsong Zhang. (2019) Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML. Blood Advances 3:9, pages 1379-1393.
Crossref
Allison L. Boyd, Lili Aslostovar, Jennifer Reid, Wendy Ye, Borko Tanasijevic, Deanna P. Porras, Zoya Shapovalova, Mohammed Almakadi, Ronan Foley, Brian Leber, Anargyros Xenocostas & Mickie Bhatia. (2018) Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence. Cancer Cell 34:3, pages 483-498.e5.
Crossref
Valerio Izzi, Juho Lakkala, Raman Devarajan, Eeva-Riitta Savolainen, Pirjo Koistinen, Ritva Heljasvaara & Taina Pihlajaniemi. (2018) Expression of a specific extracellular matrix signature is a favorable prognostic factor in acute myeloid leukemia. Leukemia Research Reports 9, pages 9-13.
Crossref
Valerio Izzi, Juho Lakkala, Raman Devarajan, Eeva‐Riitta Savolainen, Pirjo Koistinen, Ritva Heljasvaara & Taina Pihlajaniemi. (2017) Vanin 1 ( VNN1 ) levels predict poor outcome in acute myeloid leukemia . American Journal of Hematology 93:1.
Crossref
Hubert Hackl, Ksenia Astanina & Rotraud Wieser. (2017) Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia. Journal of Hematology & Oncology 10:1.
Crossref
Y. Saunthararajah. 2016. Cancer Stem Cells. Cancer Stem Cells 101 119 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.